Sign in
TerminatedNo phase

Study of Home-Embedded Palliative Care for Hemodialysis- (and Peritoneal-) Dependent End-Stage Renal Disease

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Status
Terminated
People taking part
315 people enrolled
Started
14 Dec 2023
Ended
11 Nov 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Nudge for PHPC NP Referral
Record updated
27 January 2025
Why it stopped
Effectiveness of home palliative care services could not be determined due to lower-than-expected referrals and consults in the intervention arm

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Be an adult (18 years of age or older) hospitalized at a Penn study hospital
  • AND digital signature of ESRD (N18.6) within the last 12 months
  • AND resides in the five-county area surrounding Philadelphia which is served by Penn Palliative Care Nurse Practitioner program
  • AND have one or more of the following markers of potentially unmet needs: (i) existing home care eligibility or referral for home care (but not already receiving PC); (ii) non-ambulatory status determined via nursing assessment; (iii) severe protein-calorie malnutrition; (iv) 2 or more hospitalizations within the prior year

Who cannot take part

  • Patients with functional kidney transplants
  • Patients discharged to skilled nursing facilities and LTC facilities

Where in United States

  • University of PennsylvaniaPhiladelphia, United States

About the trial

What the trial wants to find out

Home palliative care needs are often under-recognized in patients with End-Stage Renal Disease (ESRD). This pilot study is designed to evaluate the effectiveness of referrals to home palliative care services in improving patient outcomes compared with usual care among patients with ESRD admitted to a Penn hospital. Evaluating the effectiveness of home palliative care services is critical to determine whether increasing access to these services would improve patient-centered outcomes for these high-need patients

The 2 groups in the trial

  • InterventionTreatment being tested

    The inpatient care team, including the attending/ordering and covering providers, for participants in this group will receive a message from the research team identifying their patient as appropriate for home palliative care and will be asked to refer their patient for these services.

    Treatment: Nudge for PHPC NP Referral

  • Usual CareNo study treatment, for comparison

    Participants in this group will receive usual care upon discharge from the hospital. Their clinical team will not be notified that they are appropriate for home palliative care services, but they may still be referred for those services if their clinicians feel their patient will benefit.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study of Home-Embedded Palliative Care for Hemodialysis- (and Peritoneal-) Dependent End-Stage Renal Disease (SHEPHERD 2.0)
Record updated
27 January 2025